Evidence map›Paper›PMID 30038420›Full record

ArticleScientific reports2018

Impact of viral upper respiratory tract infection on the concentration of nasopharyngeal pneumococcal carriage among Kenyan children.

Susan C Morpeth, Patrick Munywoki, Laura L Hammitt, Anne Bett, Christian Bottomley, Clayton O Onyango, David R Murdoch, D James Nokes, J Anthony G Scott

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 34 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Prevention of antimicrobial prescribing among infants following maternal vaccination against respiratory syncytial virus.Proceedings of the National Academy of Sciences of the United States of America · 2022
    Trial
  4. Article
  5. Influence of Microbiota on Clinical Expressions of Respiratory Viral Infections.The American journal of tropical medicine and hygiene · 2024
    Article
  6. Article
  7. Article
  8. Frontiers in pediatrics · 2023
    Article
  9. Intracellular survival ofFrontiers in immunology · 2022
    Article
  10. Article
  11. Pneumococcal carriage in children with COVID-19.Human vaccines & immunotherapeutics · 2021
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Susan C MorpethKEMRI-Wellcome Trust Research Programme, Kilifi, 80108, Kenya. susan.morpeth@middlemore.co.nz.
Patrick MunywokiKEMRI-Wellcome Trust Research Programme, Kilifi, 80108, Kenya.
Laura L HammittKEMRI-Wellcome Trust Research Programme, Kilifi, 80108, Kenya.
Anne BettKEMRI-Wellcome Trust Research Programme, Kilifi, 80108, Kenya.
Christian BottomleyDepartment of Infectious Disease Epidemiology, the London School of Hygiene and Tropical Medicine, London, WC1E 7HT, United Kingdom.
Clayton O OnyangoKEMRI-Wellcome Trust Research Programme, Kilifi, 80108, Kenya.
David R MurdochDepartment of Pathology, University of Otago, Christchurch, New Zealand.
D James NokesKEMRI-Wellcome Trust Research Programme, Kilifi, 80108, Kenya.ORCID 0000-0001-5426-1984
J Anthony G ScottKEMRI-Wellcome Trust Research Programme, Kilifi, 80108, Kenya.ORCID 0000-0001-7533-5006
Kenya Medical Research Institute · KEUniversity of London · GBCanterbury Health Laboratories · NZJohns Hopkins University · US

Funding

GAVI Alliance (Gavi) PneumoADIPMedical Research Council MR/K012126/1Wellcome TrustWellcome Trust 090853Wellcome Trust 098532
6 · The paper itself

Abstract

Viral upper respiratory tract infection (URTI) predisposes to bacterial pneumonia possibly by facilitating growth of bacteria such as Streptococcus pneumoniae colonising the nasopharynx. We investigated whether viral URTI is temporally associated with an increase in nasopharyngeal pneumococcal concentration. Episodes of symptomatic RSV or rhinovirus URTI among children <5 years were identified from a longitudinal household study in rural Kenya. lytA and alu PCR were performed on nasopharyngeal samples collected twice-weekly, to measure the pneumococcal concentration adjusted for the concentration of human DNA present. Pneumococcal concentration increased with a fold-change of 3.80 (95%CI 1.95-7.40), with acquisition of RSV or rhinovirus, during 51 URTI episodes among 42 children. In repeated swabs from the baseline period, in the two weeks before URTI developed, within-episode variation was broad; within +/-112-fold range of the geometric mean. We observed only a small increase in nasopharyngeal pneumococcal concentration during RSV or rhinovirus URTI, relative to natural variation. Other factors, such as host response to viral infection, may be more important than nasopharyngeal pneumococcal concentration in determining risk of invasive disease.

Indexed as

Child, PreschoolFemaleHumansInfantKenyaLongitudinal StudiesMalePolymerase Chain ReactionRespiratory Tract InfectionsRhinovirusStreptococcus pneumoniae

Identifiers

PMID30038420
PMCPMC6056465
OpenAlexW2883496941

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.